Menu Search
Equities

Farmacosmo SpA

ZJ1:FRA

Farmacosmo SpA

Actions
  • Price (EUR)0.734
  • Today's Change-0.01 / -1.34%
  • Shares traded--
  • 1 Year change-5.41%
  • Beta--
Data delayed at least 15 minutes, as of Jul 05 2024 14:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Farmacosmo SpA is an Italy-based wellness e-commerce company. The Company is focused on selling pharmaceutical products through an e-commerce platform. It offers products from different brands specializing in health and wellness, organized into 15 categories, such as Health & Pharmacy, Vitamins & Supplements, Dental care, Bath & Body, Make-up, Perfumes, Organic & Natural, Pets and Household, among others. Its products include medicines and health articles, supplements, childcare products, body care and beauty products, perfumes, make-up, toys, veterinary and home care products. The Company is authorised by the Italian Ministry of Health to sell pharmaceutical products online. Farmacosmo SpA is active in Italy.

  • Revenue in EUR (TTM)71.21m
  • Net income in EUR-3.23m
  • Incorporated2012
  • Employees90.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		COSMO:MIL since
announced		Transaction
value
Frcm1 SrlAnnounced03 Aug 202303 Aug 2023Announced-20.42%339.00k
Data delayed at least 15 minutes, as of Jul 05 2024 16:35 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.